{"transactions":[{"id":1983624,"issuer":{"id":6727,"kind":"organization","name":"Coya Therapeutics, Inc."},"owners":[{"id":116239,"kind":"person","name":"Hepner Adrian","position":1,"cik":"0001637347","reported_name":"Hepner Adrian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2023-03-01T16:05:22.000Z","date":"2023-02-27","kind":"grant","acquired":true,"shares":115000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to continuous service, the shares subject to the option vest in equal monthly installments over a period of 36 months commencing on March 27, 2023."}],"balance_after":115000,"derivative":{"exercise_price":3.85,"expiration_date":"2033-02-27","underlying":"Common Stock","underlying_shares":115000},"source":{"system":"sec-edgar","filing":"0001493152-23-006390","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1637347/000149315223006390/ownership.xml","form_type":"4"}},{"id":2067609,"issuer":{"id":6727,"kind":"organization","name":"Coya Therapeutics, Inc."},"owners":[{"id":116239,"kind":"person","name":"Hepner Adrian","position":1,"cik":"0001637347","reported_name":"Hepner Adrian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Warrant to Purchase Common Stock","published_at":"2023-01-04T08:30:25.000Z","date":"2023-01-03","kind":"purchase","acquired":true,"shares":5000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reporting Person purchased 10,000 shares of Common Stock and an accompanying warrant to purchase 5,000 shares of Common Stock in the Issuer's initial public offering at a combined purchase price of $5.00 per share and accompanying warrant."}],"balance_after":5000,"derivative":{"exercise_price":7.5,"exercise_date":"2023-01-03","expiration_date":"2025-01-03","underlying":"Common Stock, par value $0.0001 per share","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001493152-23-000225","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1637347/000149315223000225/ownership.xml","form_type":"4"}},{"id":2067608,"issuer":{"id":6727,"kind":"organization","name":"Coya Therapeutics, Inc."},"owners":[{"id":116239,"kind":"person","name":"Hepner Adrian","position":1,"cik":"0001637347","reported_name":"Hepner Adrian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2023-01-04T08:30:25.000Z","date":"2023-01-03","kind":"purchase","acquired":true,"shares":10000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reporting Person purchased 10,000 shares of Common Stock and an accompanying warrant to purchase 5,000 shares of Common Stock in the Issuer's initial public offering at a combined purchase price of $5.00 per share and accompanying warrant."}],"balance_after":10000,"source":{"system":"sec-edgar","filing":"0001493152-23-000225","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1637347/000149315223000225/ownership.xml","form_type":"4"}},{"id":3301777,"issuer":{"id":85958,"kind":"organization","name":"EAGLE PHARMACEUTICALS, INC.","symbol":"EGRX"},"owners":[{"id":116239,"kind":"person","name":"Hepner Adrian","position":1,"cik":"0001637347","reported_name":"Hepner Adrian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Chief Medical Officer"}}],"security":"Common Stock","published_at":"2020-01-27T16:13:54.000Z","date":"2020-01-23","kind":"tax_withholding","acquired":false,"shares":1630,"price":57.98,"value":94507.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld to satisfy withholding tax obligations."}],"balance_after":48784,"source":{"system":"sec-edgar","filing":"0001209191-20-004986","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/827871/000120919120004986/doc4.xml","form_type":"4"}},{"id":3317001,"issuer":{"id":85958,"kind":"organization","name":"EAGLE PHARMACEUTICALS, INC.","symbol":"EGRX"},"owners":[{"id":116239,"kind":"person","name":"Hepner Adrian","position":1,"cik":"0001637347","reported_name":"Hepner Adrian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Chief Medical Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2020-01-07T18:22:45.000Z","date":"2020-01-05","kind":"grant","acquired":true,"shares":55000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option vests over a period of four years, with 25% of the shares underlying the option vesting on January 5, 2021, the first anniversary of the date of grant, and the remainder vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous service with the Issuer as of the applicable vesting date."}],"balance_after":55000,"derivative":{"exercise_price":59.795,"expiration_date":"2030-01-04","underlying":"Common Stock","underlying_shares":55000},"source":{"system":"sec-edgar","filing":"0001209191-20-002345","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/827871/000120919120002345/doc4.xml","form_type":"4"}},{"id":3317000,"issuer":{"id":85958,"kind":"organization","name":"EAGLE PHARMACEUTICALS, INC.","symbol":"EGRX"},"owners":[{"id":116239,"kind":"person","name":"Hepner Adrian","position":1,"cik":"0001637347","reported_name":"Hepner Adrian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Chief Medical Officer"}}],"security":"Common Stock","published_at":"2020-01-07T18:22:45.000Z","date":"2020-01-07","kind":"tax_withholding","acquired":false,"shares":815,"price":57.38,"value":46764.7,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents shares withheld to satisfy withholding tax obligations."}],"balance_after":50414,"source":{"system":"sec-edgar","filing":"0001209191-20-002345","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/827871/000120919120002345/doc4.xml","form_type":"4"}},{"id":3316999,"issuer":{"id":85958,"kind":"organization","name":"EAGLE PHARMACEUTICALS, INC.","symbol":"EGRX"},"owners":[{"id":116239,"kind":"person","name":"Hepner Adrian","position":1,"cik":"0001637347","reported_name":"Hepner Adrian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Chief Medical Officer"}}],"security":"Common Stock","published_at":"2020-01-07T18:22:45.000Z","date":"2020-01-05","kind":"grant","acquired":true,"shares":24000,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSUs\"). The RSUs vest over a period of four years, with 25% of the RSUs vesting on each of the one, two, three and four-year anniversaries of January 5, 2020, subject to the Reporting Person's continuous service with the Issuer as of the applicable vesting date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":51229,"source":{"system":"sec-edgar","filing":"0001209191-20-002345","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/827871/000120919120002345/doc4.xml","form_type":"4"}},{"id":3687450,"issuer":{"id":85958,"kind":"organization","name":"EAGLE PHARMACEUTICALS, INC.","symbol":"EGRX"},"owners":[{"id":116239,"kind":"person","name":"Hepner Adrian","position":1,"cik":"0001637347","reported_name":"Hepner Adrian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Chief Medical Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2019-01-25T20:04:10.000Z","date":"2019-01-23","kind":"grant","acquired":true,"shares":42500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option vests over a period of four years, with 25% of the shares underlying the option vesting on January 23, 2020, the first anniversary of the date of grant, and the remainder vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous service with the Issuer as of the applicable vesting date."}],"balance_after":42500,"derivative":{"exercise_price":42.4,"expiration_date":"2029-01-23","underlying":"Common Stock","underlying_shares":42500},"source":{"system":"sec-edgar","filing":"0001209191-19-005443","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/827871/000120919119005443/doc4.xml","form_type":"4"}},{"id":3687449,"issuer":{"id":85958,"kind":"organization","name":"EAGLE PHARMACEUTICALS, INC.","symbol":"EGRX"},"owners":[{"id":116239,"kind":"person","name":"Hepner Adrian","position":1,"cik":"0001637347","reported_name":"Hepner Adrian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-01-25T20:04:10.000Z","date":"2019-01-23","kind":"grant","acquired":true,"shares":19000,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents restricted stock units (\"RSUs\").  The RSUs vest over a period of four years, with 25% of the RSUs vesting on each of the one, two, three and four-year anniversaries of January 23, 2019, subject to the Reporting Person's continuous service with the Issuer as of the applicable vesting date."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each RSU represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":27229,"source":{"system":"sec-edgar","filing":"0001209191-19-005443","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/827871/000120919119005443/doc4.xml","form_type":"4"}},{"id":3687448,"issuer":{"id":85958,"kind":"organization","name":"EAGLE PHARMACEUTICALS, INC.","symbol":"EGRX"},"owners":[{"id":116239,"kind":"person","name":"Hepner Adrian","position":1,"cik":"0001637347","reported_name":"Hepner Adrian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-01-25T20:04:10.000Z","date":"2019-01-07","kind":"tax_withholding","acquired":false,"shares":771,"price":41.33,"value":31865.43,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld to satisfy withholding tax obligations."}],"balance_after":8229,"source":{"system":"sec-edgar","filing":"0001209191-19-005443","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/827871/000120919119005443/doc4.xml","form_type":"4"}},{"id":4103638,"issuer":{"id":85958,"kind":"organization","name":"EAGLE PHARMACEUTICALS, INC.","symbol":"EGRX"},"owners":[{"id":116239,"kind":"person","name":"Hepner Adrian","position":1,"cik":"0001637347","reported_name":"Hepner Adrian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Chief Medical Officer"}}],"security":"Performance Stock Unit","published_at":"2018-01-09T17:44:00.000Z","date":"2018-01-07","kind":"grant","acquired":true,"shares":27000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each performance stock unit (\"PSU\") represents a contingent right to receive one share of the Issuer's common stock."},{"field":"shares","element":"transactionShares","label":"F4","text":"Represents the maximum number of shares issuable under this award."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The shares issuable in respect of such PSUs shall vest on the three-year anniversary of January 1, 2018 (such three-year anniversary, the \"Vesting Date\"), based on the extent to which the following stock price hurdles are achieved for 30 consecutive trading days on or prior to the Vesting Date.  If the Issuer's stock price reaches or surpasses $85.92, $110.00, $120.00 or $134.25, then 9,000, 18,000, 22,500 or 27,000 PSUs will vest, respectively.  The number of shares issuable in respect of such PSUs vested on the Vesting Date will be determined by the highest Issuer stock price hurdle achieved.  This vesting is subject to the Reporting Person's continuous service with the Issuer as of the Vesting Date."}],"balance_after":27000,"derivative":{"expiration_date":"2021-01-01","underlying":"Common Stock","underlying_shares":27000},"source":{"system":"sec-edgar","filing":"0001209191-18-002995","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/827871/000120919118002995/doc4.xml","form_type":"4"}},{"id":4103637,"issuer":{"id":85958,"kind":"organization","name":"EAGLE PHARMACEUTICALS, INC.","symbol":"EGRX"},"owners":[{"id":116239,"kind":"person","name":"Hepner Adrian","position":1,"cik":"0001637347","reported_name":"Hepner Adrian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Chief Medical Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-01-09T17:44:00.000Z","date":"2018-01-07","kind":"grant","acquired":true,"shares":43000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests over a period of four years, with 25% of the shares underlying the option vesting on January 7, 2019, the first anniversary of the date of grant, and the remainder vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous service with the Issuer as of the applicable vesting date."}],"balance_after":43000,"derivative":{"exercise_price":59.14,"expiration_date":"2028-01-06","underlying":"Common Stock","underlying_shares":43000},"source":{"system":"sec-edgar","filing":"0001209191-18-002995","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/827871/000120919118002995/doc4.xml","form_type":"4"}},{"id":4103636,"issuer":{"id":85958,"kind":"organization","name":"EAGLE PHARMACEUTICALS, INC.","symbol":"EGRX"},"owners":[{"id":116239,"kind":"person","name":"Hepner Adrian","position":1,"cik":"0001637347","reported_name":"Hepner Adrian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-01-09T17:44:00.000Z","date":"2018-01-07","kind":"grant","acquired":true,"shares":9000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were issued pursuant to a restricted stock unit (\"RSU\") award, each RSU representing a contingent right to receive one share of the Issuer's common stock. The shares issuable in respect of such RSUs shall vest with respect to 25% of the shares of common stock on each of the one, two, three and four-year anniversaries of January 7, 2018, subject to the Reporting Person's continuous service with the Issuer as of the applicable vesting date."}],"balance_after":9000,"source":{"system":"sec-edgar","filing":"0001209191-18-002995","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/827871/000120919118002995/doc4.xml","form_type":"4"}},{"id":4497041,"issuer":{"id":85958,"kind":"organization","name":"EAGLE PHARMACEUTICALS, INC.","symbol":"EGRX"},"owners":[{"id":116239,"kind":"person","name":"Hepner Adrian","position":1,"cik":"0001637347","reported_name":"Hepner Adrian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2017-01-06T17:05:55.000Z","date":"2017-01-04","kind":"grant","acquired":true,"shares":67200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests over a period of four years, with 25% of the shares underlying the option vesting on January 4, 2018, the first anniversary of the date of grant, and the remainder vesting in 36 equal monthly installments thereafter, subject to the reporting person's continuous service with the issuer as of the applicable vesting date."}],"balance_after":67200,"derivative":{"exercise_price":84.92,"expiration_date":"2027-01-03","underlying":"Common Stock","underlying_shares":67200},"source":{"system":"sec-edgar","filing":"0001209191-17-002683","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/827871/000120919117002683/doc4.xml","form_type":"4"}}]}